MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (NASDAQ:GERN) was ranked number 5 of companies listed in the biotechnology patent scorecard published in the Feb. 12 issue of The Wall Street Journal.
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (NASDAQ:GERN) was ranked number 5 of companies listed in the biotechnology patent scorecard published in the Feb. 12 issue of The Wall Street Journal.
